Coste Catherine 4
4 · BIOLIFE SOLUTIONS INC · Filed Mar 20, 2025
Insider Transaction Report
Form 4
Coste Catherine
Director
Transactions
- Award
Common Stock
2025-03-18+5,701→ 5,701 total
Footnotes (1)
- [F1]The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the measurement date of 01-02-2025.